chr1-53459817-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033067.3(DMRTB1):āc.364C>Gā(p.Gln122Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0003 in 1,445,566 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q122K) has been classified as Uncertain significance.
Frequency
Consequence
NM_033067.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DMRTB1 | NM_033067.3 | c.364C>G | p.Gln122Glu | missense_variant | 1/4 | ENST00000371445.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DMRTB1 | ENST00000371445.3 | c.364C>G | p.Gln122Glu | missense_variant | 1/4 | 1 | NM_033067.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000981 AC: 149AN: 151878Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000241 AC: 15AN: 62254Hom.: 0 AF XY: 0.000218 AC XY: 8AN XY: 36760
GnomAD4 exome AF: 0.000220 AC: 285AN: 1293578Hom.: 1 Cov.: 31 AF XY: 0.000217 AC XY: 138AN XY: 636688
GnomAD4 genome AF: 0.000980 AC: 149AN: 151988Hom.: 0 Cov.: 32 AF XY: 0.000955 AC XY: 71AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2022 | The c.364C>G (p.Q122E) alteration is located in exon 1 (coding exon 1) of the DMRTB1 gene. This alteration results from a C to G substitution at nucleotide position 364, causing the glutamine (Q) at amino acid position 122 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at